Anti-Histone H3 (unmodified K4) antibody [RM186]
Be the first to review this product! Submit a review
|
(1 Publication)
- ICC/IF
Supplier Data
Immunocytochemistry/ Immunofluorescence - Anti-Histone H3 (unmodified K4) antibody [RM186] (AB238310)
HeLa (human epithelial cell line from cervix adenocarcinoma) cells treated with sodium butyrate stained for Histone H3 (unmodified K4) (red) using ab238310 at 2 μg/ml in ICC/IF. Actin filaments have been labeled with fluorescein phalloidin (green).``
- WB
Supplier Data
Western blot - Anti-Histone H3 (unmodified K4) antibody [RM186] (AB238310)
All lanes:
Western blot - Anti-Histone H3 (unmodified K4) antibody [RM186] (ab238310) at 1 µg/mL
Lane 1:
Acid extracts of HeLa (human epithelial cell line from cervix adenocarcinoma) cells treated with sodium butyrate
Lane 2:
Acid extracts of HeLa cells treated with Nocodazole
Lane 3:
Acid extracts of HeLa cells
Lane 4:
Recombinant Histone H3.1
Predicted band size: 15 kDa
false
- ELISA
Supplier Data
ELISA - Anti-Histone H3 (unmodified K4) antibody [RM186] (AB238310)
ab238310 specifically recognizes Histone H3 unmodified at Lys4 and does not recognize acetylated, mono-methylated, dimethylated, or trimethylated Lys4. The antibody binding specificity allows for modifications of Arg2 or Thr3 in histone H3.``
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Alternative Names
Publications (1)
Recent publications for all applications. Explore the full listand refine your search
Journal of cachexia, sarcopenia and muscle 16:e13734 PubMed39971710
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com